Contraception
Volume 81, Issue 1 , Pages 75-78 , January 2010

Cancer risk after sterilization with transcervical quinacrine: updated findings from a Chilean cohort

  • David C. Sokal

      Affiliations

    • Family Health International, Durham, NC 27709, USA
    • Corresponding Author InformationCorresponding author. Family Health International, PO Box 13950, Research Triangle Park, NC 27709, USA. Tel.: +1 919 544 7040x11232; fax: +1 919 544 7261.
  • ,
  • Valentin Trujillo

      Affiliations

    • San Jose Hospital, 8380000 Santiago, Chile
  • ,
  • Sergio C. Guzmán

      Affiliations

    • Escuela de Medicina, Universidad Austral de Chile, 5090000 Valdivia, Chile
  • ,
  • Rene Guzman-Serani

      Affiliations

    • Escuela de Medicina, Universidad Austral de Chile, 5090000 Valdivia, Chile
  • ,
  • Angie Wheeless

      Affiliations

    • Family Health International, Durham, NC 27709, USA
  • ,
  • David Hubacher

      Affiliations

    • Family Health International, Durham, NC 27709, USA

Received 3 June 2009 ,Revised 14 July 2009 ,Accepted 14 July 2009.

References 

  1. Zipper J, Trujillo V. 25 years of quinacrine sterilization experience in Chile: review of 2,592 cases. Int J Gynaecol Obstet. 2003;83(Suppl 2):S23–S29
  2. Sokal DC, Zipper J, King T. Transcervical quinacrine sterilization: clinical experience. Int J Gynaecol Obstet. 1995;51(Suppl 1):S57–69
  3. Kessel E. 100,000 quinacrine sterilizations. Adv Contracept. 1996;12:69–76
  4. Clarke JJ, Sokal DC, Cancel AM, et al. Re-evaluation of the mutagenic potential of quinacrine dihydrochloride dihydrate. Mutat Res. 2001;494:41–53
  5. Sokal DC, Zipper J, Guzman-Serani R, Aldrich TE. Cancer risk among women sterilized with transcervical quinacrine hydrochloride pellets, 1977 to 1991. Fertil Steril. 1995;64:325–334
  6. Sokal DC, Dabancens A, Guzman-Serani R, Zipper J. Cancer risk among women sterilized with transcervical quinacrine in Chile: an update through 1996. Fertil Steril. 2000;74:169–171
  7. Feldblum PJ, Hays M, Zipper J, Guzman-Serani R, Sokal DC. Pregnancy rates among Chilean women who had non-surgical sterilization with quinacrine pellets between 1977 and 1989. Contraception. 2000;61:379–384
  8. Bravo LE, Carrascal E, Collazos T, et al. Cancer incidence in Cali Colombia 1998-2002. In:  Curado MP,  Edwards B,  Shin HR, et al. editor. Cancer incidence in five continents. IARC Scientific Publications No. 160. vol. IX:Lyon: IARC; 2007;http://www-dep.iarc.fr/. On-line database accessed on January 23, 2008
  9. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents, vol. I to VIII. IARC CancerBase No. 7. Lyon: IARC; 2005;http://www-dep.iarc.fr/. On-line database accessed on January 23, 2008
  10. Smith PG, Doll R. Mortality among patients with ankylosing spondylitis after a single treatment course with x-rays. Br Med J (Clin Res Ed). 1982;284:449–460
  11. Pendlebury SC, Bilous M, Langlands AO. Sarcomas following radiation therapy for breast cancer: a report of three cases and a review of the literature. Int J Radiat Oncol Biol Phys. 1995;31:405–410
  12. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol. 1996;174:1161–1168[discussion 1168-70]
  13. Bertrán ME, Mora KE, Jofré AM. Cancer incidence in Valdivia, Chile, 1998-2002. In:  Curado MP,  Edwards B,  Shin HR, et al. editor. Cancer incidence in five continents. IARC Scientific Publications No. 160. vol. IX:Lyon: IARC; 2007;http://www-dep.iarc.fr/. Accessed on January 23, 2008
  14. Sokal DC, Vach TH, Nanda K, et al. Quinacrine sterilization and gynecologic cancers: a case-control study in Northern Vietnam. Epidemiology [in press].
  15. Dabancens A, Pruyas M, Zipper J, Rivera M, Velasco V. Intrauterine quinacrine and risk of endometrial cancer. Ginecol Reprod. 1998;6:21–26
  16. Tworoger SS, Fairfield KM, Colditz GA, Rosner BA, Hankinson SE. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. Am J Epidemiol. 2007;166:894–901

 Funding: This study was supported in part by Family Health International (FHI), with funds from an anonymous donor.

PII: S0010-7824(09)00351-5

doi: 10.1016/j.contraception.2009.07.006

Contraception
Volume 81, Issue 1 , Pages 75-78 , January 2010